Life science companies continue to struggle to leverage new AI technologies to enhance the safety and efficacy of therapeutics. The key is identifying clear use cases where AI can maximize impact by supporting bench scientists, data scientists, and medical writers. This presentation will cover three such use cases:​

1. Utilizing GPTs for structured content authoring​
2. Automating data transformation for eCTD standardization​
3. QSP model creation to improve target ID, PK/PD, and clinical trial design​